scispace - formally typeset
P

Peter Arner

Researcher at Karolinska Institutet

Publications -  565
Citations -  56932

Peter Arner is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Adipose tissue & Lipolysis. The author has an hindex of 114, co-authored 553 publications receiving 52710 citations. Previous affiliations of Peter Arner include Karolinska University Hospital & Bristol-Myers Squibb.

Papers
More filters
Journal ArticleDOI

Human White Adipose Tissue Displays Selective Insulin Resistance in the Obese State

TL;DR: Human WAT displays a selective insulin response in the obese state, where most genes are normalized by weight loss, and this comprehensive atlas provides insights into the transcriptional effects of insulin in WAT and may identify targets to improve insulin action.
Journal ArticleDOI

Left ventricular β1 and β2 adrenoceptor mRNA expression in normal and volume overloaded human heart

TL;DR: Myocardium from different parts of the normal human heart, where different pressure work is generated, express similar levels of BAR-1 and BAR-2 mRNA, which indicates an independent regulation of the expression of these two receptor subtypes.
Journal ArticleDOI

Determination of adrenoceptors of the alpha2-subtype on isolated human fat cells

TL;DR: It is concluded that the (3H)-yohimbine method can be used for the study of alpha 2-receptor properties and regulation in subcutaneous adipose tissue in a given individual.
Journal ArticleDOI

Allele-specific quantitative proteomics unravels molecular mechanisms modulated by cis-regulatory PPARG locus variation.

TL;DR: Combining bioinformatics and public domain chromatin information with quantitative proteomics supports prediction of cis-regulatory variants and enabled identification of allele-dependent binding of both, transcription factors and coregulators at the type 2 diabetes associated PPARG locus.
Journal ArticleDOI

Effect of metoprolol and alprenolol on the metabolic, hormonal, and haemodynamic response to insulin-induced hypoglycaemia in hypertensive, insulin-dependent diabetics.

TL;DR: The haemodynamic response was altered only by the non-selective alprenolol and not by the selective beta-adrenergic blocking agent (metoprolol), and the signs of hypoglycaemia were not masked.